应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NRSN Neurosense Therapeutics Ltd
盘前交易 05-01 07:44:41 EDT
1.35
+0.06
+4.65%
最高
1.37
最低
1.26
成交量
1.44万
今开
1.26
昨收
1.29
日振幅
8.33%
总市值
2,340万
流通市值
1,672万
总股本
1,733万
成交额
1.92万
换手率
0.12%
流通股本
1,238万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Neurosense Therapeutics Ltd.盘中异动 早盘股价大涨6.20%报1.37美元
自选股智能写手 · 04-30 22:25
Neurosense Therapeutics Ltd.盘中异动 早盘股价大涨6.20%报1.37美元
Neurosense Therapeutics Ltd.盘中异动 早盘急速上涨5.69%报1.30美元
自选股智能写手 · 04-29 21:52
Neurosense Therapeutics Ltd.盘中异动 早盘急速上涨5.69%报1.30美元
Neurosense Therapeutics Ltd.盘中异动 大幅下跌6.35%报1.18美元
自选股智能写手 · 04-26
Neurosense Therapeutics Ltd.盘中异动 大幅下跌6.35%报1.18美元
Neurosense Therapeutics Ltd.盘中异动 早盘快速跳水5.97%报1.26美元
自选股智能写手 · 04-25
Neurosense Therapeutics Ltd.盘中异动 早盘快速跳水5.97%报1.26美元
Neurosense Therapeutics Ltd.盘中异动 早盘股价大跌7.04%
自选股智能写手 · 04-22
Neurosense Therapeutics Ltd.盘中异动 早盘股价大跌7.04%
Neurosense Therapeutics Ltd.盘中异动 早盘快速下挫9.21%报1.38美元
自选股智能写手 · 04-19
Neurosense Therapeutics Ltd.盘中异动 早盘快速下挫9.21%报1.38美元
Neurosense Therapeutics Ltd.盘中异动 早盘股价大跌5.63%
自选股智能写手 · 04-18
Neurosense Therapeutics Ltd.盘中异动 早盘股价大跌5.63%
Neurosense Therapeutics Ltd.盘中异动 急速下挫5.45%
自选股智能写手 · 04-17
Neurosense Therapeutics Ltd.盘中异动 急速下挫5.45%
Neurosense Therapeutics Ltd.盘中异动 大幅拉升7.74%
自选股智能写手 · 04-12
Neurosense Therapeutics Ltd.盘中异动 大幅拉升7.74%
Neurosense Therapeutics Ltd.盘中异动 快速下跌6.02%
自选股智能写手 · 04-11
Neurosense Therapeutics Ltd.盘中异动 快速下跌6.02%
Neurosense Therapeutics Ltd.盘中异动 股价大跌5.02%
自选股智能写手 · 04-10
Neurosense Therapeutics Ltd.盘中异动 股价大跌5.02%
Neurosense Therapeutics Ltd.盘中异动 股价大涨10.83%报1.93美元
自选股智能写手 · 04-09
Neurosense Therapeutics Ltd.盘中异动 股价大涨10.83%报1.93美元
Neurosense Therapeutics Ltd.盘中异动 早盘股价大涨5.88%报1.80美元
自选股智能写手 · 04-08
Neurosense Therapeutics Ltd.盘中异动 早盘股价大涨5.88%报1.80美元
Neurosense Therapeutics Ltd.盘中异动 早盘股价大涨5.83%
自选股智能写手 · 04-05
Neurosense Therapeutics Ltd.盘中异动 早盘股价大涨5.83%
Neurosense Therapeutics Ltd.盘中异动 股价大跌16.07%
自选股智能写手 · 03-27
Neurosense Therapeutics Ltd.盘中异动 股价大跌16.07%
Neurosense Therapeutics Ltd.盘中异动 早盘大幅上涨7.78%报1.80美元
自选股智能写手 · 03-21
Neurosense Therapeutics Ltd.盘中异动 早盘大幅上涨7.78%报1.80美元
Neurosense Therapeutics Ltd.盘中异动 快速拉升5.09%
自选股智能写手 · 03-20
Neurosense Therapeutics Ltd.盘中异动 快速拉升5.09%
Neurosense Therapeutics Ltd.盘中异动 大幅拉升6.76%报1.50美元
自选股智能写手 · 03-19
Neurosense Therapeutics Ltd.盘中异动 大幅拉升6.76%报1.50美元
Neurosense Therapeutics Ltd.盘中异动 大幅拉升5.75%报1.47美元
自选股智能写手 · 03-15
Neurosense Therapeutics Ltd.盘中异动 大幅拉升5.75%报1.47美元
Neurosense Therapeutics Ltd.盘中异动 临近午盘急速下跌5.49%
自选股智能写手 · 03-14
Neurosense Therapeutics Ltd.盘中异动 临近午盘急速下跌5.49%
加载更多
公司概况
公司名称:
Neurosense Therapeutics Ltd
所属市场:
NASDAQ
上市日期:
--
主营业务:
NeuroSense Therapeutics Ltd.于2017年2月13日在以色列注册成立。该公司是一家临床阶段的生物技术公司,专注于发现和开发针对神经退行性疾病患者的治疗方法,包括肌萎缩性侧索硬化症(ALS)、阿尔茨海默病(AD)和帕金森病(PD)。公司的主要候选治疗药物PrimeC是一种新型的缓释口服制剂,由两种FDA批准的药物环丙沙星和塞来昔布组成的固定剂量组合。PrimeC旨在通过调节microRNA合成、铁积累和神经炎症来治疗ALS,所有这些都是ALS病理的标志。
发行价格:
--
{"stockData":{"symbol":"NRSN","market":"US","secType":"STK","nameCN":"Neurosense Therapeutics Ltd","latestPrice":1.35,"timestamp":1714507200000,"preClose":1.29,"halted":0,"volume":14392,"delay":0,"floatShares":12382921,"shares":17334042,"eps":-0.826969,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.06,"latestTime":"05-01 07:44:41 EDT","open":1.2626,"high":1.37,"low":1.2626,"amount":19185.4901896,"amplitude":0.083256,"askPrice":1.62,"askSize":100,"bidPrice":1.19,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-0.826969,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714570200000},"adr":0,"listingDate":1639026000000,"adjPreClose":1.34,"postHourTrading":{"tag":"盘后","latestPrice":1.3483,"preClose":1.35,"latestTime":"18:02 EDT","volume":1150,"amount":1547.75,"timestamp":1714514544590},"volumeRatio":0.17637514303108648},"requestUrl":"/m/hq/s/NRSN/","defaultTab":"news","newsList":[{"id":"2431432086","title":"Neurosense Therapeutics Ltd.盘中异动 早盘股价大涨6.20%报1.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431432086","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431432086?lang=zh_cn&edition=full","pubTime":"2024-04-30 22:25","pubTimestamp":1714487102,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日22时25分,Neurosense Therapeutics Ltd.股票出现波动,股价大幅上涨6.20%。截至发稿,该股报1.37美元/股,成交量6457股,换手率0.04%,振幅8.33%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体涨幅为0.73%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404302225028b669697&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404302225028b669697&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431695458","title":"Neurosense Therapeutics Ltd.盘中异动 早盘急速上涨5.69%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431695458","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431695458?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:52","pubTimestamp":1714398742,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时52分,Neurosense Therapeutics Ltd.股票出现异动,股价快速上涨5.69%。截至发稿,该股报1.30美元/股,成交量1816股,换手率0.01%,振幅3.25%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体涨幅为0.68%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429215222861ea19f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429215222861ea19f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430080982","title":"Neurosense Therapeutics Ltd.盘中异动 大幅下跌6.35%报1.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430080982","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430080982?lang=zh_cn&edition=full","pubTime":"2024-04-26 22:05","pubTimestamp":1714140353,"startTime":"0","endTime":"0","summary":"北京时间2024年04月26日22时05分,Neurosense Therapeutics Ltd.股票出现异动,股价大幅下跌6.35%。截至发稿,该股报1.18美元/股,成交量1.4639万股,换手率0.08%,振幅3.57%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体涨幅为0.01%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042622055487e84369&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042622055487e84369&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430285196","title":"Neurosense Therapeutics Ltd.盘中异动 早盘快速跳水5.97%报1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430285196","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430285196?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:33","pubTimestamp":1714052008,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时33分,Neurosense Therapeutics Ltd.股票出现异动,股价快速下跌5.97%。截至发稿,该股报1.26美元/股,成交量4436股,换手率0.03%,振幅2.24%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体跌幅为0.64%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252133287a55b358&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252133287a55b358&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429248139","title":"Neurosense Therapeutics Ltd.盘中异动 早盘股价大跌7.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429248139","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429248139?lang=zh_cn&edition=full","pubTime":"2024-04-22 21:45","pubTimestamp":1713793519,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日21时45分,Neurosense Therapeutics Ltd.股票出现波动,股价大幅下跌7.04%。截至发稿,该股报1.32美元/股,成交量11.3976万股,换手率0.66%,振幅4.23%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体涨幅为0.41%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222145207a549396&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222145207a549396&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428674665","title":"Neurosense Therapeutics Ltd.盘中异动 早盘快速下挫9.21%报1.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428674665","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428674665?lang=zh_cn&edition=full","pubTime":"2024-04-19 23:16","pubTimestamp":1713539812,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日23时16分,Neurosense Therapeutics Ltd.股票出现异动,股价大幅跳水9.21%。截至发稿,该股报1.38美元/股,成交量2.6801万股,换手率0.15%,振幅5.26%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体涨幅为0.36%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419231652861e77c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419231652861e77c7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428592320","title":"Neurosense Therapeutics Ltd.盘中异动 早盘股价大跌5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428592320","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428592320?lang=zh_cn&edition=full","pubTime":"2024-04-18 21:50","pubTimestamp":1713448237,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日21时50分,Neurosense Therapeutics Ltd.股票出现波动,股价大幅下跌5.63%。截至发稿,该股报1.51美元/股,成交量10.3798万股,换手率0.60%,振幅4.38%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体跌幅为0.79%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182150377921903a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182150377921903a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428346557","title":"Neurosense Therapeutics Ltd.盘中异动 急速下挫5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428346557","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428346557?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:38","pubTimestamp":1713361083,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时38分,Neurosense Therapeutics Ltd.股票出现波动,股价急速跳水5.45%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体涨幅为0.65%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404172138038b300aa4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404172138038b300aa4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426787127","title":"Neurosense Therapeutics Ltd.盘中异动 大幅拉升7.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426787127","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426787127?lang=zh_cn&edition=full","pubTime":"2024-04-12 21:31","pubTimestamp":1712928673,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日21时31分,Neurosense Therapeutics Ltd.股票出现异动,股价急速上涨7.74%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体跌幅为0.29%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412213113876f455d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412213113876f455d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426250790","title":"Neurosense Therapeutics Ltd.盘中异动 快速下跌6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426250790","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426250790?lang=zh_cn&edition=full","pubTime":"2024-04-11 21:31","pubTimestamp":1712842296,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日21时31分,Neurosense Therapeutics Ltd.股票出现异动,股价大幅下跌6.02%。截至发稿,该股报1.56美元/股,成交量1.497万股,换手率0.10%,振幅0.00%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体涨幅为0.32%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112131368767f9e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112131368767f9e7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426049062","title":"Neurosense Therapeutics Ltd.盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426049062","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426049062?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:53","pubTimestamp":1712757225,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时53分,Neurosense Therapeutics Ltd.股票出现波动,股价快速下挫5.02%。截至发稿,该股报1.63美元/股,成交量8452股,换手率0.05%,振幅1.16%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体跌幅为1.33%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102153457a51e8d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102153457a51e8d8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426019209","title":"Neurosense Therapeutics Ltd.盘中异动 股价大涨10.83%报1.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426019209","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426019209?lang=zh_cn&edition=full","pubTime":"2024-04-09 21:31","pubTimestamp":1712669470,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日21时31分,Neurosense Therapeutics Ltd.股票出现波动,股价急速拉升10.83%。截至发稿,该股报1.93美元/股,成交量4.5319万股,换手率0.29%,振幅3.97%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体跌幅为0.01%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409213110875a2e45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409213110875a2e45&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425988918","title":"Neurosense Therapeutics Ltd.盘中异动 早盘股价大涨5.88%报1.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425988918","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425988918?lang=zh_cn&edition=full","pubTime":"2024-04-08 21:31","pubTimestamp":1712583064,"startTime":"0","endTime":"0","summary":"北京时间2024年04月08日21时31分,Neurosense Therapeutics Ltd.股票出现波动,股价急速上涨5.88%。截至发稿,该股报1.80美元/股,成交量1.5393万股,换手率0.11%,振幅0.00%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体跌幅为0.10%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408213104791f2bd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408213104791f2bd2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425792563","title":"Neurosense Therapeutics Ltd.盘中异动 早盘股价大涨5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425792563","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425792563?lang=zh_cn&edition=full","pubTime":"2024-04-05 21:33","pubTimestamp":1712323995,"startTime":"0","endTime":"0","summary":"北京时间2024年04月05日21时33分,Neurosense Therapeutics Ltd.股票出现波动,股价快速上涨5.83%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体涨幅为0.00%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405213316791eda0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405213316791eda0f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422647701","title":"Neurosense Therapeutics Ltd.盘中异动 股价大跌16.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422647701","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422647701?lang=zh_cn&edition=full","pubTime":"2024-03-27 01:53","pubTimestamp":1711475591,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日01时53分,Neurosense Therapeutics Ltd.股票出现异动,股价急速下挫16.07%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体涨幅为0.16%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403270153127a4f3a4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403270153127a4f3a4c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421451340","title":"Neurosense Therapeutics Ltd.盘中异动 早盘大幅上涨7.78%报1.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421451340","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421451340?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:30","pubTimestamp":1711027823,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时30分,Neurosense Therapeutics Ltd.股票出现波动,股价急速拉升7.78%。截至发稿,该股报1.80美元/股,成交量895股,换手率0.01%,振幅0.00%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体涨幅为0.00%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321213023791c0566&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321213023791c0566&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420747148","title":"Neurosense Therapeutics Ltd.盘中异动 快速拉升5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420747148","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420747148?lang=zh_cn&edition=full","pubTime":"2024-03-20 21:31","pubTimestamp":1710941485,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日21时31分,Neurosense Therapeutics Ltd.股票出现波动,股价急速拉升5.09%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体跌幅为0.41%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403202131257a4df8de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403202131257a4df8de&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420462222","title":"Neurosense Therapeutics Ltd.盘中异动 大幅拉升6.76%报1.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420462222","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420462222?lang=zh_cn&edition=full","pubTime":"2024-03-19 21:31","pubTimestamp":1710855068,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日21时31分,Neurosense Therapeutics Ltd.股票出现波动,股价急速拉升6.76%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体涨幅为0.05%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403192131088b480140&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403192131088b480140&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419897242","title":"Neurosense Therapeutics Ltd.盘中异动 大幅拉升5.75%报1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419897242","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419897242?lang=zh_cn&edition=full","pubTime":"2024-03-15 21:47","pubTimestamp":1710510434,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日21时47分,Neurosense Therapeutics Ltd.股票出现波动,股价快速拉升5.75%。截至发稿,该股报1.47美元/股,成交量7693股,换手率0.06%,振幅5.22%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体涨幅为0.05%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240315214714791adb90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240315214714791adb90&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419981428","title":"Neurosense Therapeutics Ltd.盘中异动 临近午盘急速下跌5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419981428","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419981428?lang=zh_cn&edition=full","pubTime":"2024-03-14 23:51","pubTimestamp":1710431488,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日23时51分,Neurosense Therapeutics Ltd.股票出现波动,股价快速下挫5.49%。截至发稿,该股报1.55美元/股,成交量4.1254万股,换手率0.30%,振幅6.09%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体跌幅为0.29%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031423512987e78faf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031423512987e78faf&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neurosense-tx.com","stockEarnings":[{"period":"1week","weight":-0.0074},{"period":"1month","weight":-0.2582},{"period":"3month","weight":0.08},{"period":"6month","weight":1.8184},{"period":"1year","weight":-0.3541},{"period":"ytd","weight":0.7197}],"compareEarnings":[{"period":"1week","weight":-0.0073},{"period":"1month","weight":-0.0403},{"period":"3month","weight":0.0396},{"period":"6month","weight":0.1653},{"period":"1year","weight":0.2081},{"period":"ytd","weight":0.0561}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"NeuroSense Therapeutics Ltd.于2017年2月13日在以色列注册成立。该公司是一家临床阶段的生物技术公司,专注于发现和开发针对神经退行性疾病患者的治疗方法,包括肌萎缩性侧索硬化症(ALS)、阿尔茨海默病(AD)和帕金森病(PD)。公司的主要候选治疗药物PrimeC是一种新型的缓释口服制剂,由两种FDA批准的药物环丙沙星和塞来昔布组成的固定剂量组合。PrimeC旨在通过调节microRNA合成、铁积累和神经炎症来治疗ALS,所有这些都是ALS病理的标志。","exchange":"NASDAQ","name":"Neurosense Therapeutics Ltd","nameEN":"Neurosense Therapeutics Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Neurosense Therapeutics Ltd(NRSN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Neurosense Therapeutics Ltd(NRSN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Neurosense Therapeutics Ltd,NRSN,Neurosense Therapeutics Ltd股票,Neurosense Therapeutics Ltd股票老虎,Neurosense Therapeutics Ltd股票老虎国际,Neurosense Therapeutics Ltd行情,Neurosense Therapeutics Ltd股票行情,Neurosense Therapeutics Ltd股价,Neurosense Therapeutics Ltd股市,Neurosense Therapeutics Ltd股票价格,Neurosense Therapeutics Ltd股票交易,Neurosense Therapeutics Ltd股票购买,Neurosense Therapeutics Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Neurosense Therapeutics Ltd(NRSN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Neurosense Therapeutics Ltd(NRSN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}